The lactose permease of Escherichia coli (LacY), a dynamic polytopic membrane protein, catalyzes galactoside-H + symport and operates by an alternating access mechanism that exhibits multiple conformations, the distribution of which is altered by sugar binding. We have developed single-domain camelid nanobodies (Nbs) against a mutant in an outward (periplasmic)-open conformation to stabilize this state of the protein. Here we describe an X-ray crystal structure of a complex between a double-Trp mutant (Gly46→Trp/Gly262→Trp) and an Nb in which free access to the sugar-binding site from the periplasmic cavity is observed. The structure confirms biochemical data indicating that the Nb binds stoichiometrically with nanomolar affinity to the periplasmic face of LacY primarily to the C-terminal six-helix bundle. The structure is novel because the pathway to the sugar-binding site is constricted and the central cavity containing the galactoside-binding site is empty. Although Phe27 narrows the periplasmic cavity, sugar is freely accessible to the binding site. Remarkably, the side chains directly involved in binding galactosides remain in the same position in the absence or presence of bound sugar.
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X-ray structure | bioenergetics | membrane transporter | fluorescence | kinetics T he lactose permease of Escherichia coli (LacY) catalyzes the coupled transport of a galactopyranoside and an H + (galactoside-H + symport) across the cytoplasmic membrane (reviewed in refs. [1] [2] [3] . Therefore, in the presence of an H + electrochemical gradient (ΔμH+; interior negative and/or alkaline), galactopyranosides can be concentrated 50-to 100-fold over the external concentration (4, 5) . However, due to the activity of β-galactosidase, no free lactose is found within the cell under physiological conditions. So why does E. coli need an active transport system for lactose? The answer lies in the kinetics, as the major effect of ΔμH+ is to decrease the K m for transport (6, 7) . By increasing the kinetic efficiency of LacY, ΔμH+ enables the cell to assimilate lactose effectively even when the environmental concentration is low.
Initial X-ray crystal structures of conformationally restricted LacY (8) (9) (10) , as well as WT LacY (11) , exhibit the same inwardfacing conformation, with an aqueous cavity widely open on the cytoplasmic side and a tightly sealed periplasmic side. Extensive mutagenesis and biochemical assays localized the sugar-and H + -binding sites to the middle of the molecule (reviewed in refs. [1] [2] [3] . This outward-closed/inward-open conformation clearly prevails in the absence of sugar (12) (13) (14) (15) (16) . More recently, a stable outward-open, nontransporting mutant was engineered with Trp replacements for two periplasmic Gly residues in the N-and C-terminal halves of LacY (17) . X-ray structures of the doubleTrp mutant G46W/G262W (LacY ww ) with either of two bound lactose homologs, 4-nitrophenyl-α-D-galactopyranoside (NPG) or β-D-galactopyranosyl-1-thio-β-D-galactopyranoside (TDG), display a conformation with a narrowly open periplasmic pathway and a tightly sealed cytoplasmic side (18, 19) . These structures confirm the location of the sugar-binding site in the middle of the molecule, define the side chains that determine specificity for galactopyranosides, and indicate that an occluded conformation(s) is an intermediate in the transport cycle. The overall transport mechanism involves alternating access of galactoside-and H + -binding sites to either side of the membrane as the result of reciprocal opening/ closing of cavities on the periplasmic and cytoplasmic sides of the molecule (reviewed in ref. 20) . This alternating access mechanism is driven by sugar binding and dissociation and is independent of Δμ̃H+, which acts kinetically (3).
Rates of opening/closing of the periplasmic and cytoplasmic cavities have been determined in real time from changes in fluorescence of Trp or attached fluorophores with LacY either solubilized in detergent micelles or reconstituted into proteoliposomes (PLs) (21) (22) (23) . Sugar-binding rates with WT LacY in PLs measured by Trp151→NPG FRET are independent of sugar concentration, whereas the LacY ww mutant is characterized by a linear concentration dependence of sugar-binding rates that approximates diffusion-controlled access to the binding site via an open periplasmic cavity (17, 22) . Therefore, with WT LacY embedded in PLs the periplasmic side is sealed, and substrate binding is limited by opening of the periplasmic cavity. The rate of opening is similar to the turnover number of WT LacY in right-side-out Significance LacY catalyzes the coupled transport (symport) of a galactosidic sugar and an H + and is the poster child for the major facilitator superfamily, the largest family of membrane transport proteins. A detailed mechanism has been postulated involving alternating access of sugar-and H + -binding sites to either side of the membrane that is driven by sugar binding and dissociation and independent of the H + electrochemical gradient, which acts kinetically. To characterize structural intermediates in the transport cycle, stable conformers are essential, and camelid single-domain nanobodies (Nbs) are particularly useful in this context. Described herein is a structure of a LacY-Nb complex in which access to the sugar-binding site from the periplasmic cavity is diffusion-limited.
membrane vesicles (24) , which suggests that opening of the periplasmic cavity may be the limiting step in the transport mechanism. To characterize intermediates in the LacY transport cycle, stable conformers are essential, particularly with respect to crystallization, and remarkable progress has been made in this direction with G protein-coupled receptors through the use of camelid single-domain nanobodies (Nbs) (25) (26) (27) (28) (29) . Nbs are small in size and have a unique structure that allows flexible loops with complementarity-determining regions (CDRs) to insert into nooks and crannies. Nbs developed against the periplasmic-open conformation of LacY ww have been shown to block transport activity in WT LacY by stabilizing various outward-open conformations (30, 31) . Here we report an X-ray crystal structure of a LacY ww -Nb 9039 complex in the absence of sugar (apo LacY ww -Nb 9039). The Nb forms multiple contacts with the periplasmic face of the C-terminal six-helix bundle and within the relatively narrow opening of the periplasmic cavity. CDR3 of the Nb is inserted into the opening between N-and C-terminal six-helix bundles of LacY in a manner that stabilizes a periplasmic-open conformation.
Results
The Global Fold. LacY ww was cocrystallized with Nb 9039 in the absence of sugar by using lipidic cubic phase crystallization, and the structure was determined to 3.5-Å resolution (Fig. 1, Figs . S1 and S2, and Movie S1). Data collection and refinement statistics are summarized in Table S1 . Crystals of the apo LacY ww -Nb complex are in space group P4 1 The structure is in an outward (periplasmic)-facing conformation with a tightly sealed cytoplasmic side that is very similar to two previous LacY ww structures with bound substrates (18, 19) . Thus, the apo LacY ww -Nb structure can be superimposed on the LacY ww -TDG structure (PDB ID code 4OAA) with an rmsd of 0.6 Å and on the LacY ww -NPG structure (PDB ID code 4ZYR) with an rmsd of 0.5 Å. The observed differences in the structural models are located on the periplasmic side of apo LacY ww .
The narrowest part of the periplasmic entrance pathway is at Phe27 (Fig. 2A) . Changes in the current structure relative to that of LacY ww with bound sugar (18, 19) involve the area of a kink in transmembrane helix 1 (TM1) around Phe27. In contrast, organization of the central cavity, which contains the substrate-binding site, is virtually identical in the apo LacY ww -Nb complex and LacY ww -TDG structures ( Fig. 2A) . Because access to the sugarbinding site is relatively narrow near the side chain of Phe27, the apo LacY ww -Nb complex structure resembles an outward-open partially occluded conformation. Further comparison of the two structures reveals that the N-terminal six-helical bundle, particularly the periplasmic ends of TM1 and TM3, shifts more than the C-terminal six-helical bundle (Fig. 2B) . Therefore, the N-terminal domain may contribute more to the opening dynamics of the periplasmic cavity.
Interaction Between Apo LacY ww and Nb 9039. The Nbs, 9039 in particular, bind to LacY ww with 1:1 stoichiometry, which is apparent from the X-ray structure of the complex ( Fig. 1 ) as well as from biochemical assays (30, 31) . The interface is formed mainly by the variable regions of the Nb and periplasmic aspect of the apo LacY ww C-terminal domain ( Fig. 3 and Fig. S3 ). In the apo LacY ww -Nb complex, part of the variable CDR3 sequence in the Nb (Ala100 to Arg115) forms a large loop that extends into the crevice between the N-and C-terminal helix bundles, creating a bridge across the periplasmic entrance to the cavity.
Although the placement of side chains is relatively imprecise at 3.5-Å resolution, the densities for the interacting residues are well-defined. Of the 11 hydrogen bonds observed in the interface between the C-terminal domain of apo LacY ww and Nb 9039, three are single hydrogen bonds and two are hydrogen bond networks ( Fig. 3 and Fig. S3 ). A single hydrogen bond is formed between Ser54 of the Nb (CDR2) and Thr310 of the apo LacY ww loop between TM9 and TM10 (loop 9-10), with the carbonyl oxygen of the Ser54 main chain acting as a hydrogen-bond acceptor from the β-OH of Thr310. Another single hydrogen bond is found between Glu112 of the Nb (CDR3) and Gly254 of apo LacY ww TM8, with the oxygen of the γ-carboxyl group of Glu112 acting as the acceptor from the main-chain amino group of Gly254. A third hydrogen bond is formed between the amino group of Arg101 from Nb (CDR3) and carboxyl group of Glu374 from apo LacY ww TM11.
In addition to the single hydrogen-bond pairs, a hydrogenbond network is formed by CDR3 in the Nb that involves Tyr110 and Thr111 interacting with Phe251 and Ala252 in loop 7-8 of apo LacY ww . The main-chain carbonyl oxygens of Phe251 and Ala252 in apo LacY ww are hydrogen-bond acceptors from the main-chain amino group of Tyr110 in the Nb, which forms two hydrogen bonds. The main-chain amino group of Thr111 in the Nb also donates another hydrogen bond to the main-chain carbonyl oxygen of Ala252 in apo LacY ww , making a total of three hydrogen bonds in this network.
The other hydrogen-bond network is composed of five hydrogen-bond pairs. Asn245 of apo LacY ww located in TM7, two helical turns inside the cavity, plays the central role in this network. The β-carboxamide of Asn245 acts as a hydrogenbond acceptor from the main-chain amino group of Ser103 in the Nb. The β-carboxamide of Asn245 also participates as a hydrogen-bond donor to the oxygen in the β-carboxyl group of Asp107 in the Nb. In addition, the main-chain carbonyl oxygen of Asn245 accepts two hydrogen bonds from the two η-amino groups of Arg115 in the Nb, and the η-amino group of Arg115 forms another hydrogen bond with the β-OH of Thr248 in apo LacY ww TM7.
Asn245 in TM7 of apo LacY ww contacts Ser103 and Asp107 in the CDR3 loop of the Nb as described, forcing Tyr104, Ser105, and Gly106 into a turn, which extends toward the N-terminal sixhelix bundle (Fig. 3, Fig. S3 , and Movie S1). As a result, the side chain of Tyr104 at the tip of the loop is in close proximity to TM1 and forms a hydrogen bond with the amino group of Lys42 in TM2 within the opening of the periplasmic cavity.
The Sugar-Binding Site. Although there are structural changes observed on the periplasmic side of LacY ww in the presence of Nb 9039 ( Fig. 2A) , it is remarkable that the side chains comprising the empty substrate-binding site in the central cavity appear to remain essentially unchanged (Fig. 4) . The densities for the side chains forming the sugar-binding site are well-defined. Thus, close inspection of the residues directly involved in binding the sugar indicates that they are positioned almost identically in the apo LacY ww -Nb structure presented here and the structures of LacY ww with bound substrate (PDB ID codes 4OAA and 4ZYR) 18, 19) . The side chains involved in binding either TDG (Fig. 4A) or NPG (Fig. 4B) include Glu126, Arg144, Trp151, Tyr236, Glu269, Asn272, and His322. In addition, Phe20 is in van der Waals contact with the anomeric moiety of the lactose homologs. The position of these side chains is virtually identical in the structures shown. However, a significant change in the position of Phe27 is observed (Fig. 4 A and B) , which corresponds to the shift of the periplasmic end of TM1 (Fig. 2) . , respectively ( Fig. 5C and Fig. S4C ). Dramatically different data are obtained with WT LacY (Fig. 5D and Fig. S4D ). In the absence of Nb 9039, the rate of sugar binding (21 ± 4 s −1
; black squares in Fig. 5D ) is independent of sugar concentration, because opening of the periplasmic cavity is rate-limiting (22) . However, the WT LacY-Nb 9039 complex exhibits a k on of 9.7 ± 0.1 μM
, indicating free access of NPG to the sugar-binding site (Fig. 5D,  red symbols) . Therefore, Nb 9039 stabilizes the periplasmic-open conformation of WT LacY in a manner similar to that shown for the apo LacY ww -Nb 9039 complex.
Asn245 in the LacY ww -Nb complex forms multiple hydrogen bonds with the CDR3 loop as described above, and plays an important role in the interaction with Nb. Indeed, replacement of Asn245 with Cys practically eliminates the stabilizing effect of Nb 9039 on the conformation of WT LacY (Fig. S5) . Addition of the Nb to the N245C mutant has little effect on sugar accessibility, because k on for NPG increases only slightly (from 0.19 ± 0.01 μM (Fig. 5B) . Notably, the N245C mutation does not alter the transport activity of LacY (34) or the kinetics of sugar binding (Fig. S5) . The 10-fold lower k on observed for sugar binding by the N245C LacY-Nb complex relative to the WT LacY-Nb complex is clearly consistent with the crystallographic data regarding the importance of Asn245 for interaction with the CDR3 loop of Nb 9039.
Discussion
The LacY ww -Nb 9039 structure described here is remarkable in several respects: (i) The structure clearly confirms biochemical observations indicating that the Nb binds stoichiometrically with nanomolar affinity to the periplasmic aspect of LacY; (ii) the structure is unique in that the apo LacY ww moiety is outward-open with narrow access to an empty central cavity; (iii) although CDR3 of the Nb, as well as Phe27 of TM1, may restrict access to the sugarbinding site, NPG binding rates indicate free access for sugar; and (iv) the side chains directly involved in liganding galactopyranosides remain in the same position in the absence or presence of sugar.
i) The Nb exhibits a dozen contacts with apo LacY ww that clearly contribute to high-affinity binding. The Nb 9039 epitope in LacY ww includes residues from TM7 (Asn245 and Thr248), loop 7-8 (Phe251 and Ala252), TM8 (Gly254), loop 9-10 (Thr310), TM11 (Glu374), and also TM2 (Lys42). In particular, Asn245, which is located in TM7 about 10 Å inside the periplasmic cavity, contacts Ser103, Asp107, and Arg115 in the CDR3 loop. A Cys in place of Asn245 is highly exposed only when the periplasmic cavity is open and is readily labeled by maleimides (13, 35, 36) . Although LacY with a single Cys in place of Asn245 exhibits normal transport activity, the effect of Nb 9039 on NPG accessibility to the binding site is dramatically reduced, thereby demonstrating the importance of Asn245 in the insertion of the CDR3 into the periplasmic cavity. Furthermore, the CDR3 loop of the Nb extends from the C-terminal helix bundle to the N-terminal bundle, with Tyr104 making contact with Lys42 within the entrance to the periplasmic cavity. Insertion of the CDR3 loop into crevices is a characteristic feature of Nbs (26, 27) and, in the case of LacY, a specific structure is formed that prevents closure of the periplasmic cavity. ii) As shown in Fig. 2A , there is a water-filled cavity leading to the chamber in the middle of LacY ww that contains the sugar-binding site but is devoid of bound sugar. The overall dimensions of the chamber are the same in the absence or presence of bound sugar. Furthermore, each of the side chains involved in sugar binding occupies the same position in the absence of bound substrate. iii) Surprisingly, although it has long been thought that reciprocal opening/closing of the periplasmic and cytoplasmic cavities involves large openings/closings, the present findings indicate that considerably smaller excursions are involved in allowing access to the central sugar-binding site from the periplasmic side. Although the CDR3 loop forms a bridge between the C-and N-terminal helix bundles that may restrict access to the sugarbinding site, two openings are present on either side of the bridge that provide pathways for sugar entrance (Movie S1). It is also apparent that Phe27 forms the narrowest portion of the periplasmic entrance (∼4 Å; Fig. 2A ). Although Phe27 could act as a gate, this seems unlikely, as the F27C mutant exhibits normal transport activity (37, 38) . Moreover, the side chain of Phe27 is not present in the overall density map contoured at 1.0 σ, unlike surrounding residues with well-defined densities, indicating high mobility of the Phe27 side chain. Despite the constrictions, it is apparent that in the apo LacY ww -Nb 9039 complex, access of NPG to the binding site is diffusioncontrolled. Therefore, side-chain movements, rather than large conformational changes, are likely involved in facilitating sugar access to the binding site via the periplasmic pathway. The size of the opening of the periplasmic cavity in the structural model of the LacY ww -Nb 9039 complex is in agreement with previous data obtained from thiol cross-linking experiments with homobifunctional reagents of different lengths (15) . Maximum lactose transport activity was observed with completely cross-linked double-Cys mutants by flexible reagents greater than 15 Å in length. In the crystal structure presented here, the distances measured between Cβ-atoms of the same pairs of residues used for cross-linking range from 16 to 20 Å. Similar distances were also obtained by double electron-electron resonance measurements (14) . iv) As indicated, the side chains directly involved in galactopyranoside binding and specificity remain in what appears to be the same position whether or not substrate is bound. Because K D = k off /k on , the increase in affinity observed upon Nb binding to WT LacY may be due to the increased accessibility to the sugar-binding site from the periplasm (k on ) rather than a conformational change in the binding site.
Although a WT LacY-Nb structure is not yet available, it is notable that the effect of Nb 9039 on the kinetics of NPG binding by WT LacY is markedly different from that observed with apo LacY ww (Fig. 5) . Thus, a dramatic increase in k on is observed upon Nb binding to WT LacY to the level shown with the apo LacY ww mutant in the absence or presence of Nb. Because the kinetics of sugar binding to apo LacY ww is not affected by interaction with Nb 9039, the conformation is probably not changed by Nb binding. It is very likely that WT LacY in complex with Nb 9039 is stabilized in a conformation similar to that observed in the X-ray structure. WT LacY is a highly dynamic protein exhibiting multiple conformers, so that only a fraction of the outward-open form is present at any time. The Nb recognizes a specific configuration of key residues in the epitope and binds to WT LacY when its conformation resembles that of the apo LacY ww mutant with exposed target residues on the periplasmic side. The CDR3 loop prevents periplasmic cavity closure and therefore stabilizes outward-open conformers, allowing sugar access to the binding site but blocking movements necessary for sugar transport across the membrane.
Materials and Methods
Materials used in this study and detailed protocols for protein purification, crystallization, and structure determination are described in SI Materials and Methods. All animal vaccination experiments were executed in strict accordance with good animal practices, following the EU animal welfare legislation and after approval of the local ethical committee (Ethical Committee for Use of Laboratory Animals of the Vrije Universiteit Brussel, VUB project 13-601-1). Every effort was made to minimize suffering.
Production of Nb 9039. Discovery of Nb 9039 against G46W/G262W LacY mutant was published previously (30) . Expression and purification of Nb 9039 is described in detail in SI Materials and Methods.
LacY Expression and Purification. LacY ww was expressed in E. coli BL21 (DE3) cells. Membranes were prepared and solubilized in dodecyl-β-D-maltopyranoside (DDM). LacY ww was then purified using immobilized metal ion affinity chromatography. Superdex 200 gel filtration was applied after LacY-Nb 9039 complex formation as described in detail in SI Materials and Methods.
Crystallization, Data Collection, and Structure Determination. The lipidic cubic phase method was used for crystallization of the apo LacY ww -Nb 9039 complex.
Datasets were collected at SPring-8 beamline BL32XU. The structure was solved by molecular replacement. Details are given in SI Materials and Methods.
Stopped-Flow Measurements. Rates of Nb binding to LacY were measured using Trp→NPG FRET by recording Trp fluorescence decrease. Stopped-flow measurements were performed at 25°C on an SFM-300 rapid kinetic system equipped with a TC-50/10 cuvette (dead time 1.2 ms) and MOS-450 spectrofluorimeter (Bio-Logic). NPG binding was measured at excitation 295 nm, with emission interference filters (Edmund Optics) at 340 nm.
Production of Nb 9039 and purification and reconstitution of LacY were carried out as described previously (30) . The LacY-Nb 9039 complex was formed by mixing 20 to 30 μM LacY with 1.5 to 2 molar excess of Nb for 30 min at room temperature in 50 mM NaP i (pH 7.5) containing 0.02% DDM or, in the case of reconstituted LacY, in the absence of DDM. Stopped-flow traces were recorded at final concentrations of 0.5 to 1.0 μM LacY after mixing with NPG. Typically, 10 to 30 traces were recorded for each data point, averaged, and fitted with an exponential equation using the built-in Bio-Kine32 software package (Bio-Logic) or by using SigmaPlot 10 (Systat Software). Calculated SDs were within 10% for each presented data point. All given concentrations were final after mixing.
